ZTS
ZTS
NYSE · Pharmaceuticals

Zoetis Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$126.89
-0.39 (-0.31%)
As of Feb 21, 12:06 AM ET ·
Analyst Consensus
Buy
24
Analysts
High
Coverage
Buy 16 67%
Hold 8 33%
Sell 0 0%
Price Target
Analyst Price Target +65.4% upside
Low Target $137.04
Average Target $209.87
High Target $267.95
Current Price $126.89
Current
$126.89
Target
$209.87
$137.04 $209.87 avg $267.95
Scenario Analysis
Bear Case
$137.04
8.0%
Low target
Base Case
$209.87
+65.4%
Avg target
Bull Case
$267.95
+111.2%
High target
Risk/Reward
13.9x
Highly favorable
Price in Context
52-Week High
$177.00
-28.3% from high
52-Week Low
$115.25
+10.1% from low
50-Day SMA
$124.55
+1.9% vs SMA
200-Day SMA
$142.48
-10.9% vs SMA
RSI (14)
62.1
Neutral
Target vs 52W High
$209.87
+18.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
 Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
 Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
 Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
 Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
 Buy 18 61% $122.82 +670.0%